BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7424559)

  • 21. Value of high contrast medium dose in brain CT.
    Raininko R; Majurin ML; Virtama P; Kangasniemi P
    J Comput Assist Tomogr; 1982 Feb; 6(1):54-7. PubMed ID: 7069012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic?
    Krause W
    Invest Radiol; 1996 Feb; 31(2):91-100. PubMed ID: 8750444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of contrast materials by experimental acute myocardial infarctions: a preliminary report.
    Higgins CB; Sovak M; Schmidt W; Siemers PT
    Invest Radiol; 1978; 13(4):337-9. PubMed ID: 689828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of computed tomography and nephrography in quantitative comparison of urographic contrast agents.
    Wilson BC; Evill CA
    Radiology; 1981 Jul; 140(1):127-34. PubMed ID: 7244214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress.
    Ryan PJ; Davis MA; DeGaeta LR; Woda B; Melchior DL
    Radiology; 1984 Sep; 152(3):759-62. PubMed ID: 6611564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different needles for percutaneous injections.
    Sudheendra D; Léger R; Groppo ER; Sun D; Durrani AK; Neeman Z; Wood BJ
    Cardiovasc Intervent Radiol; 2007; 30(1):151-2. PubMed ID: 16988874
    [No Abstract]   [Full Text] [Related]  

  • 27. Simple weight-based contrast dosing for standardization of portal phase CT liver enhancement.
    Benbow M; Bull RK
    Clin Radiol; 2011 Oct; 66(10):940-4. PubMed ID: 21724182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of iosulamide meglumine as a contrast material for intravenous cholangiography: an experimental study in dogs.
    Berk RN; Barnhart JL; Nazareno G; Witt BL
    Invest Radiol; 1981; 16(3):240-4. PubMed ID: 7263160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bowel opacification using "Telebrix 38" for CT scanning.
    Azouz EM; Hassell P; Nogrady MB; Di Paolo M
    J Can Assoc Radiol; 1982 Dec; 33(4):233-5. PubMed ID: 7161301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio- and hemodynamic characterization of X-ray contrast media after intravascular administration.
    Mannesmann G; Müller B; Goedecke H; Maass B
    Pharmacol Ther B; 1979; 5(1-3):115-24. PubMed ID: 493305
    [No Abstract]   [Full Text] [Related]  

  • 31. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
    Spataro RF; Fischer HW; Kormano M
    Invest Radiol; 1984; 19(6 Suppl):S372-5. PubMed ID: 6511276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous infusion of urographic contrast agents on glomerular filtration rate, serum concentration and urinary excretion of uric acid in subjects with normal renal function.
    Jacobs C; Nicolay D; Grellet J; Curet P; Jardin A
    Adv Exp Med Biol; 1987; 212():145-50. PubMed ID: 3618354
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative evaluation of biliary x-ray contrast agents in computed tomography.
    Evill CA; Wilson BC; Benness GT
    Australas Radiol; 1983 Nov; 27(3):258-62. PubMed ID: 6675660
    [No Abstract]   [Full Text] [Related]  

  • 35. Three-dimensional helical computed tomographic cholangiography: application to living related hepatic transplantation.
    Cheng YF; Lee TY; Chen CL; Huang TL; Chen YS; Lui CC
    Clin Transplant; 1997 Jun; 11(3):209-13. PubMed ID: 9193844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contrast media enhancement in cranial computed tomography --studies of iodinated contrast infusion (ICI)].
    Sato O; Kanazawa I; Kamitani H; Yamashita M; Sano K
    No To Shinkei; 1976 Nov; 28(11):1225-33. PubMed ID: 1036028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Product selection criteria for intravascular ionic contrast media.
    Swanson DP; Dick TJ; Simms SM; Thrall JH
    Clin Pharm; 1985; 4(5):527-38. PubMed ID: 3902331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contrast amplification of the liver parenchyma in the computer tomogram by using intravenous and peroral biliary contrast media (author's transl)].
    Justich E; Sager WD; Dietrich G; Fotter R; zur Nedden D
    Rontgenblatter; 1980 May; 33(5):226-31. PubMed ID: 7375767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional imaging of the liver. New information from dynamic CT.
    Axel L; Dean PB; Moss AA; Stansberry D
    Invest Radiol; 1984; 19(1):23-9. PubMed ID: 6323343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion.
    Blomley MJ; Coulden R; Bufkin C; Lipton MJ; Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S72-7; discussion S78. PubMed ID: 8282508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.